Paper4149232
Allogeneic marrow grafting for treatment of aplastic anemia.
Storb R and 9 others. Blood, 1974. Cited by 360 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Allogeneic marrow grafting for treatment of aplastic anemia. Papers, record 4149232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4149232
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Aplastic | Major topic |
| Bone Marrow Cells | Major topic |
| Bone Marrow Transplantation | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Blood Platelets | |
| Blood Transfusion | |
| Bone Marrow Examination | |
| Child | |
| Child, Preschool | |
| Cyclophosphamide | |
| Female | |
| Furosemide | |
| Graft vs Host Reaction | |
| Histocompatibility Testing | |
| Humans | |
| Leukocytes | |
| Lymphocyte Culture Test, Mixed | |
| Male | |
| Methotrexate | |
| Middle Aged | |
| Radiation Effects | |
| Sex Chromosomes | |
| Transplantation Immunology | |
| Transplantation, Homologous |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 360 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,054,108 | History of hematopoietic cell transplantation: challenges and progress. | Haematologica | 2020 | https://conductscience.org/library/papers/33054108 | PubMed |
| 28,655,810 | Antithymocyte globulin and transplants for aplastic anemia. | Haematologica | 2017 | https://conductscience.org/library/papers/28655810 | PubMed |
| 27,517,222 | Bone marrow transplantation in aplastic anaemia. | Ir J Med Sci | 1976 | https://conductscience.org/library/papers/27517222 | PubMed |
| 27,479,689 | Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD? | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/27479689 | PubMed |
| 27,011,200 | Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies. | Viruses | 2016 | https://conductscience.org/library/papers/27011200 | PubMed |
| 26,797,402 | Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions. | Biol Blood Marrow Transplant | 2016 | https://conductscience.org/library/papers/26797402 | PubMed |
| 25,665,040 | Alternative donor transplant of benign primary hematologic disorders. | Bone Marrow Transplant | 2015 | https://conductscience.org/library/papers/25665040 | PubMed |
| 22,315,497 | Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. | Haematologica | 2012 | https://conductscience.org/library/papers/22315497 | PubMed |
| 21,152,385 | Hematopoietic cell transplantation for treatment of primary immune deficiencies. | Cell Ther Transplant | 2010 | https://conductscience.org/library/papers/21152385 | PubMed |
| 20,151,032 | Current and future approaches for control of graft-versus-host disease. | Expert Rev Hematol | 2008 | https://conductscience.org/library/papers/20151032 | PubMed |
| 18,022,575 | HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. | Biol Blood Marrow Transplant | 2007 | https://conductscience.org/library/papers/18022575 | PubMed |
| 17,326,240 | The HLA system: genetics, immunology, clinical testing, and clinical implications. | Yonsei Med J | 2007 | https://conductscience.org/library/papers/17326240 | PubMed |
| 15,565,456 | Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care. | J Cancer Res Clin Oncol | 2005 | https://conductscience.org/library/papers/15565456 | PubMed |
| 14,530,878 | Hematopoietic stem cell transplantation for severe aplastic anemia--experience of an institute in Taiwan. | Ann Hematol | 2004 | https://conductscience.org/library/papers/14530878 | PubMed |
| 12,430,936 | Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children. | Int J Hematol | 2002 | https://conductscience.org/library/papers/12430936 | PubMed |
| 11,939,259 | Stem cell transplantation for aplastic anemia. | Int J Hematol | 2002 | https://conductscience.org/library/papers/11939259 | PubMed |
| 11,108,304 | Hospital capacity and post-transplant survival after allogeneic bone marrow transplantation: analysis of data from the Japan Society for Hematopoietic Cell Transplantation. | Bone Marrow Transplant | 2000 | https://conductscience.org/library/papers/11108304 | PubMed |
| 7,654,856 | Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results. | Ann Hematol | 1995 | https://conductscience.org/library/papers/7654856 | PubMed |
| 7,044,963 | Alternatives to donor matching for control of graft-versus-host disease. | Immunogenetics | 1982 | https://conductscience.org/library/papers/7044963 | PubMed |
| 7,037,074 | Recent developments in allogeneic marrow transplantation for the treatment of severe aplastic anemia. | Blut | 1981 | https://conductscience.org/library/papers/7037074 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4149232
GET https://conductscience.org/api/papers/v1/4149232/cited_by?page=2